Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Daptomycin→

Daptomycin Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
103060-53-3
Molecular formula
C72H101N17O26
Molecular weight
1620.7 g/mol
Drug class
Lipopeptide AntibacterialAntibioticLipopeptides
Mechanism of action
Daptomycin is an antibacterial drug [see Clinical Pharmacology ( 12.4 )] .
Indications / reported uses
  • Bacteremia
  • Skin Diseases, Bacterial
  • pneumonia
  • left-sided infective endocarditis due to S
  • adult patients with Staphylococcus aureus bloodstream infections (bacteremia), including adult patients with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolates

Sources: FDA product labels (openFDA) · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Daptomycin Environmental Risk Assessment (ERA) (the Daptomycin ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.